Key takeaways:
Wegovy HD contains a higher dose of semaglutide (7.2 mg) than regular Wegovy injections. It’s designed for people using the 2.4 mg Wegovy dose who may need additional weight loss.
Higher Wegovy doses may lead to greater weight loss. But they can also increase the risk of side effects.
The best option for you depends on your weight-loss goals, response to treatment, and how well you tolerate the medication.
Save on related medications
A higher-dose version of Wegovy — called Wegovy HD — offers a new option for weight loss. But how does it compare to regular Wegovy?
Both versions contain the same active ingredient (semaglutide), but Wegovy HD delivers a higher dose. This may lead to greater weight loss for some people. If you’ve hit a plateau with regular Wegovy, your prescriber may recommend switching to Wegovy HD.
Here’s how Wegovy HD compares to regular Wegovy, including key differences in doses, effectiveness, and side effects.
Wegovy HD vs. regular Wegovy comparison
Here’s a quick summary of the differences between Wegovy HD and regular Wegovy injections.
| Wegovy | Wegovy HD | |
|---|---|---|
| Approved populations | Adults and adolescents ages 12 and older | Adults only |
| Available dose(s) |
|
|
| Dosage schedule | Starting dosage: 0.25 mg weekly, with dose increases every 4 weeks Maximum dosage: 2.4 mg weekly |
After using the 2.4 mg Wegovy dose for at least 4 weeks, start Wegovy HD at 7.2 mg weekly |
| Weight loss (from comparison study) | Average weight loss of about 16% | Average weight loss of about 19% |
| Side effects | Common side effects are gastrointestinal (GI), such as nausea and diarrhea | GI side effects and abnormal skin sensations are more common with Wegovy HD |
Below, we take a closer look at four key differences.
1. Wegovy HD contains 3 times more semaglutide than the highest regular Wegovy dose
Wegovy HD contains a higher dose of semaglutide than regular Wegovy. It delivers up to three times more medication than the standard maintenance dose — 7.2 mg vs. 2.4 mg. Like regular Wegovy, Wegovy HD is still injected once a week.
Regular Wegovy is typically increased up to a maximum maintenance dose of 2.4 mg once weekly (or 1.7 mg if not tolerated). Wegovy HD increases this ceiling, offering a higher-dose option for people who may need additional support after reaching and tolerating the standard dosage schedule.
2. Wegovy HD and regular Wegovy are used in different situations
Wegovy HD and regular Wegovy are both FDA approved for weight loss, but they’re not always used in the same situations. Wegovy HD is typically considered for people who need to achieve more weight loss or who haven’t reached their goals with standard doses.
Regular Wegovy is the starting point. It’s prescribed alongside lifestyle changes, such as a nutritious diet and regular exercise. It’s approved for use among certain adults and adolescents age 12 and older. In addition to weight loss, regular Wegovy doses are used for cardiovascular risk reduction and treating metabolic dysfunction-associated steatohepatitis (a type of fatty liver disease).
Wegovy HD may be an option for adults who’ve already tried and tolerated the highest regular Wegovy dose. Your prescriber may consider increasing to a higher dose if your weight loss has plateaued and if additional weight loss would provide meaningful health benefits.
3. Wegovy HD can lead to greater weight loss than regular Wegovy
Wegovy HD can lead to greater average weight loss compared with regular Wegovy. Clinical trial data suggests that higher doses of semaglutide may result in additional weight loss for some people.
One study compared Wegovy HD to regular Wegovy (2.4 mg). After 72 weeks (about 17 months), people receiving Wegovy HD lost about 19% of their starting body weight on average. People in the regular Wegovy group lost about 16%. Those who remained on treatment the entire trial lost about 21% with Wegovy HD and 18% with Wegovy 2.4 mg.
However, results can vary from person to person. Some people achieve significant weight loss with standard doses alone. But others may benefit from a higher dose if they’re able to tolerate it.
4. Side effects may be more likely with Wegovy HD
Side effects may be more common with Wegovy HD compared with regular Wegovy. This is because higher doses increase the medication’s effects in the body.
Common side effects of Wegovy HD and regular Wegovy include:
Nausea
Vomiting
Diarrhea
Constipation
Stomach upset
In clinical trials, gastrointestinal side effects were more common with Wegovy HD. Dysesthesia (abnormal skin sensations) was also more common.
More serious side effects and risks are also possible with Wegovy, including:
Low blood glucose (sugar)
Pancreatitis (inflammation of the pancreas)
Gallbladder problems
Acute kidney problems
Severe gastroparesis (slowed stomach emptying)
Worsening of diabetes-related eye problems
Your healthcare team will monitor you and may adjust your dose based on how well you tolerate treatment.
Which option is right for you?
The choice between Wegovy HD and regular Wegovy depends on your individual goals, response to treatment, and how well you tolerate side effects.
As mentioned, regular Wegovy is the starting point, since it’s effective for many people and allows your body to gradually adjust to the medication. If you’re losing weight steadily and tolerating it well, you may not need a higher dose.
Wegovy HD may be worth discussing with your prescriber if:
Your weight loss has slowed or plateaued.
You need additional weight loss for health reasons.
You’ve tolerated lower doses without significant side effects.
Your healthcare professional can help weigh the potential benefits and risks and decide whether increasing your dose makes sense for you.
The bottom line
Wegovy HD is a higher-dose version of semaglutide that may lead to greater weight loss than regular Wegovy injections. But the added benefits can come with a higher risk of side effects.
Regular Wegovy works well for many people and is usually the first option. Wegovy HD may be considered if you need additional weight loss and can tolerate a higher dose.
The best choice between Wegovy and Wegovy HD depends on your personal response to treatment and should be made with guidance from your healthcare team.
Why trust our experts?


References
Novo Nordisk. (2025). Novo Nordisk files for FDA approval of a higher dose of Wegovy injection 7.2 mg.
Novo Nordisk. (2026). FDA approves Novo Nordisk's new Wegovy HD injection, delivering the highest weight loss to date for a Wegovy injection, adding to its already expansive clinical profile.
Novo Nordisk. (2026). Wegovy (semaglutide) injection 1.7 mg | 2.4 mg | 7.2 mg [package insert].
Wharton, S., et al. (2025). Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. The Lancet.









